bioAffinity Technologies annual shares outstanding
2021
2022
2023
2024
2025
bioAffinity Technologies Shares Outstanding History (BIAF)
bioAffinity Technologies reported 4.5M shares outstanding at the end of fiscal 2025.
View full bioAffinity Technologies company overviewbioAffinity Technologies annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.5M | 4.0M | +766.53% |
| 2024 | 2024-12-31 | 519,158 | −8.9M | −94.47% |
| 2023 | 2023-12-31 | 9.4M | 1.0M | +12.09% |
| 2022 | 2022-12-31 | 8.4M | 5.7M | +213.07% |
| 2021 | 2021-12-31 | 2.7M | — | — |
bioAffinity Technologies quarterly shares outstanding
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 6.8M | −21.7M | −76.17% |
| Q1 2026 | 2026-03-31 | 4.5M | −13.8M | −75.36% |
| Q4 2025 | 2025-12-31 | 4.5M | −11.1M | −71.12% |
| Q3 2025 | 2025-09-30 | 3.5M | −10.0M | −74.18% |
| Q2 2025 | 2025-06-30 | 28.5M | 17.0M | +147.75% |
| Q1 2025 | 2025-03-31 | 18.3M | 7.0M | +62.76% |
| Q4 2024 | 2024-12-31 | 15.6M | 6.2M | +65.80% |
| Q3 2024 | 2024-09-30 | 13.4M | 4.2M | +45.65% |
| Q2 2024 | 2024-06-30 | 11.5M | 2.9M | +34.27% |
| Q1 2024 | 2024-03-31 | 11.2M | 2.8M | +32.53% |
| Q4 2023 | 2023-12-31 | 9.4M | 1.0M | +12.09% |
| Q3 2023 | 2023-09-30 | 9.2M | 847,133 | +10.12% |
| Q2 2023 | 2023-06-30 | 8.6M | 5.9M | +219.57% |
| Q1 2023 | 2023-03-31 | 8.5M | — | — |
| Q4 2022 | 2022-12-31 | 8.4M | — | — |
| Q3 2022 | 2022-09-30 | 8.4M | — | — |
| Q4 2021 | 2021-12-31 | 2.7M | — | — |
bioAffinity Technologies shares outstanding trends
Across the available reported history, bioAffinity Technologies's shares outstanding moved from 519,158 to 4.5M, a change of 4.0M. The latest reported quarter, Q2 2026, shows 6.8M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review bioAffinity Technologies filings at SEC.gov ↗